Order Article Reprints

Arenas Jimenez MD, González-Parra E, Riera M, Rincón Bello A, López-Herradón A, Cao H, Hurtado S, Collado S, Ribera L, Barbosa F, et al. Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients. 2021; 13(8):2559. https://doi.org/10.3390/nu13082559

Arenas Jimenez, María Dolores, Emilio González-Parra, Marta Riera, Abraham Rincón Bello, Ana López-Herradón, Higini Cao, Sara Hurtado, Silvia Collado, Laura Ribera, Francesc Barbosa, and et al. 2021. "Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics" Nutrients 13, no. 8: 2559. https://doi.org/10.3390/nu13082559

Arenas Jimenez, M. D., González-Parra, E., Riera, M., Rincón Bello, A., López-Herradón, A., Cao, H., Hurtado, S., Collado, S., Ribera, L., Barbosa, F., Dapena, F., Torregrosa, V., Broseta, J.-J., Soto Montañez, C., Navarro-González, J. F., Ramos, R., Bover, J., Nogués-Solan, X., Crespo, M., ... Pascual, J. (2021). Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients, 13(8), 2559. https://doi.org/10.3390/nu13082559